What is risnia used for?

RISNIA MD 1MG TABLET belongs to a group of medicines called ‘antipsychotics’ used to treat schizophrenia and manic depression (or bipolar disorder). RISNIA MD 1MG TABLET also treats short-term treatment of long-term aggression in people with Alzheimer’s dementia, and mentally disabled children.

Is risnia same as risperidone?

Risperidone(Risperdal Consta ) generic Risnia (2 mg) is an atypical antipsychotic, prescribed for Asperger’s syndrome (difficulties in social interaction), schizophrenia (disturbed or unusual thinking), schizoaffective disorder(elevated or depressed mood), the mixed and manic states associated with bipolar disorder.

Is Risperidone safe long-term?

What are the potential long-term effects of taking Risperdal? Your doctor should monitor for progression of potential long-term side effects of Risperdal, which can include changes in heart rhythm, weight gain, high blood sugar, and tardive dyskinesia.

What can be used as a substitute for risnia 1 mg?

Below is the list of medicines, which have the same composition, strength and form as Risnia 1 MG Tablet , and hence can be used as its substitute. What are the dosage instructions?

What does Cipla do for Public Health in India?

Through its wide-ranging relief efforts, the Company is focusing on initiatives that have the maximum impact and reach. It is currently supporting public health institutions, frontline healthcare workers, vulnerable patients and communities struggling in the aftermath.

What are the side effects of risnia 1 mg?

It is also used for treating irritability symptoms in children suffering from autism. Risnia 1 MG Tablet helps in restoring the balance of neurotransmitters (chemical messengers) in the brain, which can eventually reduce the symptoms associated with psychotic disorders.

Who is the CEO of Cipla Pharmaceutical Company?

CNBC International’s Tanvir Gill and Nancy Hungerford interact with Umang Vohra to discuss the company’s performance, play in COVID-19 and future outlook and plans. Umang talks about how only 5% of the company’s sales come from Remdesivir and the COVID related portfolio, and that the company is also doing incredibly well beyond the COVID portfolio.